Site Search

Share

X

Search Results

ACS CAN Issues New Recommendations to Increase Access to Cancer Biomarker Testing

Washington, D.C.– The American Cancer Society Cancer Action Network (ACS CAN) released new policy recommendations today to increase uptake of biomarker testing and advance the use of precision medicine in cancer care. The recommendations follow the release of new data that shows access is not keeping up with innovation when it comes to biomarker testing.  Progress in improving cancer outcomes increasingly involves the use of precision medicine, which uses information about a ...

Cancer Survivors Convene in Hartford, Urge Lawmakers to Expand Access to Biomarker Testing

... diseases like cancer. With this in mind, the volunteers asked lawmakers to improve private insurance coverage of comprehensive cutting edge biomarker testing across all communities. Last year, the legislature acted to ensure such access for Medicaid enrollees, but private insurance companies were not included. Because insurance coverage of biomarker testing has not kept pace with the speed of medical innovation, communities in Connecticut are facing significant disparities in who is ...

State Senate Committee Votes to Increase Access to Innovative Testing and Lifesaving Treatments

... here . Sacramento, Calif. –  The California Senate Health Committee voted Wednesday evening to advance a bill that would increase access to biomarker testing, a critical step in accessing precision medicine treatments that can lead to fewer side effects, improved survival, better quality of life and potentially lower costs for cancer patients.  Senate Bill 912 would ensure comprehensive biomarker testing is covered by more insurance plans, including Medi-Cal, when supported by medical and scientific evidence. The bill moves on to ...

Vermont Cancer Advocates Convene at State House to Urge Lawmakers to Expand Access to Biomarker Testing

... diseases like cancer. With this in mind, the volunteers will be asking lawmakers to improve insurance coverage of comprehensive cutting edge biomarker testing across all communities. Lawmakers will hear from dozens of survivors, caregivers and advocates, including Jason Kirchick an oncology nurse ... make this a reality if lawmakers pass H136, requiring all insurers to cover this lifesaving, cutting edge, form of precision medicine known as biomarker testing.” Because insurance coverage of biomarker testing has not kept pace with the speed of medical innovation, communities in ...

Governor Ducey Signs Legislation to Increase Access to Innovative Testing that Can Match Patients with Most Effective Treatments

Phoenix, Ariz. – Today, Governor Doug Ducey signed legislation that will ensure biomarker testing is covered by more insurance plans, including Medicaid, when patients need it. The new law will enable more Arizonans to benefit from biomarker testing, a critical step in accessing precision medicine treatments that can lead to fewer side effects, improved survival, better ...

California Assembly Committee Passes Legislation Requiring More Insurance Plans Cover Biomarker Testing Needed for Many Innovative Cancer Treatments

Sacramento, Calif. – June 21, 2022 – The California Assembly Health Committee passed a bill today that would ensure comprehensive biomarker testing is covered by more insurance plans, including Medi-Cal, when supported by medical and scientific evidence. If signed into law, Senate Bill 912 will enable more Californians to benefit from biomarker testing, a critical step in accessing precision medicine treatments that can lead to fewer side effects, improved survival, better ...

Cancer Advocates Urge California Governor to Sign Legislation Expanding Access to Biomarker Testing Needed for Many Innovative Treatments

Sacramento, Calif. –  The California Legislature passed a bill last night that would ensure comprehensive biomarker testing is covered by more health insurance plans, including Medi-Cal, when supported by medical and scientific evidence. Senate Bill 912 – which ... was introduced by Senator Monique Limón (D-Santa Barbara) – has received unanimous, bipartisan support throughout the legislative process. Biomarker testing is a critical step in accessing precision medicine treatments that can lead to fewer side effects, improved survival, better ...

Advocates Hold Cancer Action Day at State House, Urging Lawmakers to Expand Access to Biomarker Testing & Address Affordability Concerns

... voice with lawmakers by holding an annual Cancer Action Day.  Specifically, the advocates urged support of a proposal to improve access to biomarker testing (SB 120) and legislation relative to insurance cost sharing calculations (SB 17). They also asked lawmakers to protect level funding for ... Program, the Breast & Cervical Cancer Screening Program and the State Cancer Registry. Volunteers met with lawmakers to discuss the role of biomarker testing in connecting patients with the precision medicine treatments that have been proven to reduce risk of death and improve quality ...

FL Legislative Briefing: The Promise of Precision Medicine in Cancer Care: Improving Patient Access to Targeted Cancer Therapies - A Virtual Event

... an overview of the rapidly advancing world of precision medicine in cancer care, as well as the importance of increasing patient access to biomarker testing and targeted cancer therapies.  A panel of experts will discuss exciting recent developments in precision medicine, the current landscape in terms of patient access to appropriate biomarker testing, and strategies to reduce barriers to testing.    PANELISTS: Moderator: Michael Diaz, MD, Assistant Managing Physician & ...

New Paper Finds Barriers to Equitable Discovery and Implementation of Pharmacogenomic Testing in Cancer Care Despite its Power to Improve Patient Outcomes

... February 22, 2024 – A new paper released today in the Journal of Clinical Oncology    finds that while incorporating pharmacogenomic (PGx) testing into cancer care can help improve patient outcomes, barriers to PGx testing, discovery, and implementation are impacting its adoption and ... from them.” ACS CAN is working to improve access to PGx testing through its state advocacy work to expand insurance coverage of comprehensive biomarker testing, which includes PGx testing. Biomarker testing is a critical step toward accessing precision medicine, including targeted therapies; however, not all patients who could benefit ...

Type

Priority Issue

State

Policy Issue

Judicial Advocacy